Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Stéphanie, Tardif"'
Publikováno v:
European Journal of Pharmacology. 669:51-58
N-desmethylclozapine (NDMC or norclozapine) is the major active metabolite of the antipsychotic clozapine in humans. The activity of NDMC differs from clozapine at a number of neurotransmitter receptors, probably influencing the pharmacological effec
Publikováno v:
Journal of receptor and signal transduction research. 36(2)
The appearance of "bell"- (or "inverted U"-) shaped agonist concentration-response curves (CRCs) in in vitro pharmacological experiments is a frequently observed but poorly communicated phenomenon. In the context of G protein coupled receptor researc
Autor:
Stéphanie Tardif, Amélie Tourette, David Troulier, Antoine Dumoulin, Marie‐Thérèse Calmettes, Delphine Denais-Lalieve, Marie-Christine Ailhaud, Claudie Cathala, Luc De Vries, Isabelle Rauly-Lestienne, Anne-Dominique Degryse, Emilie Lauressergues, Didier Cussac, Fabrice Lestienne, Peter Heusler
Publikováno v:
Pharmacology Research & Perspectives
The Hedgehog (HH) pathway has been linked to the formation of basal cell carcinoma (BCC), medulloblastoma, and other cancers. The recently approved orally active drugs vismodegib (GDC‐0449) and sonidegib (LDE–225) were not only efficacious for th
Autor:
Emmanuel Naline, Peter Heusler, Thierry Clerc, Didier Cussac, Stéphanie Tardif, Philippe Devillier
Publikováno v:
Pharmacological research. 100
The anticholinergic properties of the mequitazine enantiomer V0162 make it a drug candidate for the treatment of chronic obstructive airway diseases. Here, we compared V0162’s in vitro pharmacological activity at recombinant human M 3 muscarinic ac
Autor:
Stéphanie Tardif, Petrus J. Pauwels
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 366:134-141
The hypothesis that prolonged treatment of a constitutively active receptor with inverse agonists may lead to increased receptor density was tested for the alpha(2)-adrenoceptor (AR) inverse agonist (+)-RX 811059 at both the wild-type (WT) and Thr(37
Publikováno v:
Biochemical Pharmacology. 62:723-732
G-protein activation and Ca 2+ responses by the wild-type D 2short receptor and a mutation Thr 343 Arg, in the distal BBX X B motif of its third intracellular loop, were investigated in CHO-K1 cells in terms of ligand:receptor:G-protein interactions.
Publikováno v:
British Journal of Pharmacology. 134:88-97
Antipsychotic drugs may mediate their therapeutic effects not only by preventing the binding of dopamine but also by decreasing the propensity of the dopamine receptor to assume an active R* state. Ligand-mediated activation and blockade of the recom
Publikováno v:
Neuropharmacology. 38:1035-1041
The activity state of G proteins is involved in the ligands' maximal responses that can be produced by activating the 5-HT1A receptor (Pauwels et al., 1997). The present study investigated the ligand responses at the recombinant h 5-HT1A receptor (RC
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 356:551-561
G-protein activation by different 5-HT receptor ligands was investigated in h5-HT1A receptor-transfected C6-glial and HeLa cells using agonist-stimulated [35S]GTPγS binding to membranes in the presence of excess GDP. 5-HT (10 μM) stimulated [35S]GT
Publikováno v:
European journal of pharmacology. 669(1-3)
N-desmethylclozapine (NDMC or norclozapine) is the major active metabolite of the antipsychotic clozapine in humans. The activity of NDMC differs from clozapine at a number of neurotransmitter receptors, probably influencing the pharmacological effec